English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Healthcare & Pharm
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025
Feb 14, 2025 20:00 HKT
CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024
Feb 12, 2025 08:00 HKT
An Incredible KLAS Triple-Award Win for AGFA HealthCare!
Feb 10, 2025 22:00 HKT
Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment
Feb 04, 2025 18:00 HKT
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10
Jan 24, 2025 23:00 HKT
Transforming Philippine Healthcare: The 2025 Philippine Hospital & Healthcare Digitalization Summit
Jan 20, 2025 16:59 HKT
Where is the next Chinese drug that will make MNCs compete to grab orders?
Jan 09, 2025 21:34 HKT
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type
Jan 09, 2025 08:00 HKT
Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
Jan 08, 2025 22:30 HKT
Combat Holiday Stress and Protect Your Immunity with LAC This Christmas!
Jan 03, 2025 10:00 HKT
Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy
Jan 02, 2025 10:52 HKT
Global Humanitarian Gurudev Sri Sri Ravi Shankar to Give Keynote Address at United Nations World Meditation Day, Followed by Live Global Meditation
Dec 19, 2024 15:30 HKT
Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area
Dec 18, 2024 14:29 HKT
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY
Dec 17, 2024 10:58 HKT
Fosun Bolsters Core Business with Two Key Asset Privatizations
Dec 13, 2024 11:25 HKT
Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau
Dec 12, 2024 12:11 HKT
Everest Medicines: Accelerating Innovation in Renal Disease to Forge a Path Toward Biopharma Leadership
Dec 11, 2024 11:06 HKT
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
Dec 09, 2024 13:00 HKT
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day
Dec 04, 2024 14:30 HKT
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
Dec 04, 2024 11:08 HKT
Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: